<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>More than 40% of HIV-infected patients on highly active antiretroviral therapy (HAART) experience <z:e sem="disease" ids="C0856151" disease_type="Disease or Syndrome" abbrv="">fat redistribution</z:e> (<z:hpo ids='HP_0009125'>lipodystrophy</z:hpo>), a syndrome associated with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> primarily affecting insulin-stimulated nonoxidative <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism (NOGM(ins)) </plain></SENT>
<SENT sid="1" pm="."><plain>Skeletal muscle biopsies, obtained from 18 lipodystrophic nondiabetic patients (LIPO) and 18 nondiabetic patients without <z:hpo ids='HP_0009125'>lipodystrophy</z:hpo> (NONLIPO) before and during hyperinsulinemic (40 mU.m(-2).min(-1))-euglycemic clamps, were analyzed for insulin signaling effectors </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were on HAART </plain></SENT>
<SENT sid="3" pm="."><plain>Both LIPO and NONLIPO patients were normoglycemic (4.9 +/- 0.1 and 4.8 +/- 0.1 mmol/l, respectively); however, NOGM(ins) was reduced by 49% in LIPO patients (P &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>NOGM(ins) correlated positively with insulin-stimulated <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthase activity (I-form, P &lt; 0.001, n = 36) </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="15" ids="28087">Glycogen</z:chebi> synthase activity (I-form) correlated inversely with phosphorylation of <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthase sites 2+2a (P &lt; 0.001, n = 36) and sites 3a+b (P &lt; 0.001, n = 36) during clamp </plain></SENT>
<SENT sid="6" pm="."><plain>Incremental <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthase-kinase-3alpha and -3beta phosphorylation was attenuated in LIPO patients (Ps &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Insulin-stimulated Akt Ser473 and Akt Thr308 phosphorylation was decreased in LIPO patients (P &lt; 0.05), whereas insulin receptor substrate-1-associated phosphatidylinositol (PI) 3-kinase activity increased significantly (P &lt; 0.001) and similarly (NS) in both groups during clamp </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, low <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthase activity explained impaired NOGM(ins) in HIV <z:hpo ids='HP_0009125'>lipodystrophy</z:hpo>, and insulin signaling defects were downstream of PI 3-kinase at the level of Akt </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggest mechanisms for the <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> greatly enhancing the risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in HIV <z:hpo ids='HP_0009125'>lipodystrophy</z:hpo> </plain></SENT>
</text></document>